These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10965707)

  • 1. Nitric oxide: modulation of the pulmonary circulation.
    Bigatello LM
    Minerva Anestesiol; 2000 May; 66(5):307-13. PubMed ID: 10965707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled nitric oxide as a selective pulmonary vasodilator in clinical anesthesia.
    Morris GN; Rich GF
    AANA J; 1997 Feb; 65(1):59-67. PubMed ID: 9223941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pulmonary hypertension: the role of nitric oxide in adults].
    Neidecker J
    Rev Esp Anestesiol Reanim; 2001 Dec; 48(10):457-9. PubMed ID: 11792299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide: an environmental pollutant as a therapeutic agent.
    Giacoia GP
    J Okla State Med Assoc; 1995 Jan; 88(1):17-23. PubMed ID: 7897549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled nitric oxide decreases pulmonary soluble guanylate cyclase protein levels in 1-month-old lambs.
    Thelitz S; Bekker JM; Ovadia B; Stuart RB; Johengen MJ; Black SM; Fineman JR
    J Thorac Cardiovasc Surg; 2004 May; 127(5):1285-92. PubMed ID: 15115984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of inhaled nitric oxide in newborn medicine.
    Golombek SG
    Heart Dis; 2000; 2(5):342-7. PubMed ID: 11728280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of inhaled nitric oxide on pulmonary vascular hyperpermeability in sheep following smoke inhalation.
    Enkhbaatar P; Kikuchi Y; Traber LD; Westphal M; Morita N; Maybauer MO; Maybauer DM; Herndon DN; Traber DL
    Burns; 2005 Dec; 31(8):1013-9. PubMed ID: 16288960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pro: Inhaled nitric oxide should be used routinely in patients undergoing lung transplantation.
    Lang JD; Lell W
    J Cardiothorac Vasc Anesth; 2001 Dec; 15(6):785-9. PubMed ID: 11748534
    [No Abstract]   [Full Text] [Related]  

  • 9. [Role of nitric oxide in respiratory physiology and in the physiopathology of pulmonary diseases].
    Dinh-Xuan AT
    Rev Mal Respir; 1996; 13(4):381-8. PubMed ID: 8927791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic and oxygenation changes of combined therapy with inhaled nitric oxide and inhaled aerosolized prostacyclin.
    Rocca GD; Coccia C; Pompei L; Ruberto F; Venuta F; De Giacomo T; Pietropaoli P
    J Cardiothorac Vasc Anesth; 2001 Apr; 15(2):224-7. PubMed ID: 11312484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide in the pulmonary vasculature.
    Coggins MP; Bloch KD
    Arterioscler Thromb Vasc Biol; 2007 Sep; 27(9):1877-85. PubMed ID: 17541026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of iNO in the modulation of pulmonary vascular resistance.
    Bin-Nun A; Schreiber MD
    J Perinatol; 2008 Dec; 28 Suppl 3():S84-92. PubMed ID: 19057617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothesis: selective phosphodiesterase-5 inhibition improves outcome in preeclampsia.
    Downing JW; Ramasubramanian R; Johnson RF; Minzter BH; Paschall RL; Sundell HW; Engelhardt B; Lewis R
    Med Hypotheses; 2004; 63(6):1057-64. PubMed ID: 15504576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled nitric oxide therapy decreases the risk of cerebral palsy in preterm infants with persistent pulmonary hypertension of the newborn.
    Tanaka Y; Hayashi T; Kitajima H; Sumi K; Fujimura M
    Pediatrics; 2007 Jun; 119(6):1159-64. PubMed ID: 17545384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitrotyrosine and NO synthases in infants with respiratory failure: influence of inhaled NO.
    Aikio O; Vuopala K; Pokela ML; Andersson S; Hallman M
    Pediatr Pulmonol; 2003 Jan; 35(1):8-16. PubMed ID: 12461733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled nitric oxide improves oxygenation in very premature infants with low pulmonary blood flow.
    Desandes R; Desandes E; Droullé P; Didier F; Longrois D; Hascoët JM
    Acta Paediatr; 2004 Jan; 93(1):66-9. PubMed ID: 14989442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose phosphodiesterase inhibition improves responsiveness to inhaled nitric oxide in isolated lungs from endotoxemic rats.
    Klein A; Zils U; Bopp C; Gries A; Martin E; Gust R
    J Surg Res; 2007 Apr; 138(2):224-30. PubMed ID: 17275845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease.
    Schulze-Neick I; Hartenstein P; Li J; Stiller B; Nagdyman N; Hübler M; Butrous G; Petros A; Lange P; Redington AN
    Circulation; 2003 Sep; 108 Suppl 1():II167-73. PubMed ID: 12970227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble guanylate cyclase activator reverses acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs.
    Evgenov OV; Ichinose F; Evgenov NV; Gnoth MJ; Falkowski GE; Chang Y; Bloch KD; Zapol WM
    Circulation; 2004 Oct; 110(15):2253-9. PubMed ID: 15466650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled nitric oxide in the term newborn.
    Kinsella JP
    Early Hum Dev; 2008 Nov; 84(11):709-16. PubMed ID: 18930613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.